0
Skip to Content
Wesana Health
Current Page: Team
Newsroom
Contact
Investors
Wesana Health
Current Page: Team
Newsroom
Contact
Current Page: Team
Newsroom
Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Stock Information
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Governance
    • Board of Directors
    • Governance Documents
  • SEDAR
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jun 01, 2021 7:37am EDT

Wesana Announces Participation at Upcoming Events in June 2021

May 27, 2021 8:57am EDT

Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

May 21, 2021 7:45am EDT

Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer

May 13, 2021 7:30am EDT

The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury

May 10, 2021 7:30am EDT

Wesana Health Commences Trading on the CSE

May 06, 2021 5:02pm EDT

Wesana Health Announces Closing of Reverse Takeover Transaction

Apr 28, 2021 8:00am EDT

Wesana Health and Debut Announce Receipt of Conditional Approval for CSE Listing

Apr 27, 2021 8:00am EDT

Wesana Health Adds Israel Mirsky as Chief Strategy Officer

Mar 31, 2021 7:30am EDT

Wesana Health Announces Closing of C$16.1 Million Oversubscribed Private Placement

Jan 21, 2021 7:30am EST

Wesana Health Closes $4 Million Convertible Note Round

  • Previous
  • 1
  • 2
  • 3
  • 4
RSS
  • email Email Alerts
  • location_city Company Profile
  • perm_contact_calendar Contacts
  • rss_feed RSS News Feed

© Wesana Health